Device Recall: ZOLL AutoPulse NXT Resuscitation System
Device may fail to deliver adequate CPRUrgent Class I Medical Device Recall
ZOLL Circulation, Inc. has issued a Class I recall of its AutoPulse NXT Resuscitation System (Model 200, Software Version 2.0.1) due to a system error that may cause the device to stop chest compressions or deliver compressions that are too shallow.
Device Use
The AutoPulse NXT is a battery-powered CPR device used on adults with no pulse or spontaneous breathing. It automates chest compressions and is intended for emergency use when CPR is needed.
What’s the Problem?
A failure code (FC1060) in the AutoPulse NXT prevents the device from correctly measuring compression depth. This could result in interrupted or inadequate CPR, posing serious risks such as:
- Reduced blood flow to vital organs
- Anoxic brain injury (due to lack of oxygen)
- Death
No injuries or deaths have been reported so far.
Affected Devices
- Product: AutoPulse NXT Platform
- Model: 200
- Catalog Number: 8700-001070-1
- Software Version: 2.0.1
A full list of affected devices follows this post.
What You Should Do
Zoll’s March 4, 2025 Urgent Medical Device Recall Notice advises:
- Immediately stop using any affected AutoPulse NXT units
- Return devices to ZOLL upon receipt of a loaner platform
- ZOLL will repair and retest devices by replacing the faulty center pulley assembly
Questions?
Contact ZOLL Circulation, Inc. at 408-541-2140 for more information.
Read the FDA recall warning here.
See recent device recalls here.
Affected Devices
|
UDI |
Serial Number |
| (01) 00849111003384 | 1179 |
| (01) 00849111003384 | 1168 |
| (01) 00849111003384 | 1178 |
| (01) 00849111003384 | 1184 |
| (01) 00849111003384 | 1188 |
| (01) 00849111003384 | 1197 |
| (01) 00849111003384 | 1109 |
| (01) 00849111003384 | 1110 |
| (01) 00849111003384 | 1126 |
| (01) 00849111003384 | 1166 |
| (01) 00849111003384 | 1169 |
| (01) 00849111003384 | 1152 |
| (01) 00849111003384 | 1199 |
| (01) 00849111003384 | 1202 |
| (01) 00849111003384 | 1111 |
| (01) 00849111003384 | 1185 |
| (01) 00849111003384 | 1198 |
| (01) 00849111003384 | 1203 |
| (01) 00849111003384 | 1206 |
| (01) 00849111003384 | 1208 |
| (01) 00849111003384 | 1211 |
| (01) 00849111003384 | 1212 |
| (01) 00849111003384 | 1172 |
| (01) 00849111003384 | 1182 |
| (01) 00849111003384 | 1130 |
| (01) 00849111003384 | 1128 |
| (01) 00849111003384 | 1129 |
| (01) 00849111003384 | 1189 |
| (01) 00849111003384 | 1183 |
| (01) 00849111003384 | 1131 |
| (01) 00849111003384 | 1134 |
| (01) 00849111003384 | 1191 |
| (01) 00849111003384 | 1186 |
| (01) 00849111003384 | 1192 |
| (01) 00849111003384 | 1170 |
| (01) 00849111003384 | 1173 |
| (01) 00849111003384 | 1175 |
| (01) 00849111003384 | 1180 |
| (01) 00849111003384 | 1174 |
| (01) 00849111003384 | 1176 |
| (01) 00849111003384 | 1187 |
| (01) 00849111003384 | 1177 |
| (01) 00849111003384 | 1116 |
| (01) 00849111003384 | 1165 |
| (01) 00849111003384 | 1118 |
| (01) 00849111003384 | 1119 |
| (01) 00849111003384 | 1193 |
| (01) 00849111003384 | 1138 |
| (01) 00849111003384 | 1139 |
| (01) 00849111003384 | 1145 |
| (01) 00849111003384 | 1146 |
| (01) 00849111003384 | 1147 |
| (01) 00849111003384 | 1148 |
| (01) 00849111003384 | 1149 |
| (01) 00849111003384 | 1150 |
| (01) 00849111003384 | 1153 |
| (01) 00849111003384 | 1155 |
| (01) 00849111003384 | 1159 |
| (01) 00849111003384 | 1161 |
| (01) 00849111003384 | 1162 |
| (01) 00849111003384 | 1163 |
| (01) 00849111003384 | 1164 |
| (01) 00849111003384 | 1181 |
| (01) 00849111003384 | 1141 |
| (01) 00849111003384 | 1108 |
| (01) 00849111003384 | 1190 |
| (01) 00849111003384 | 1195 |
| (01) 00849111003384 | 1120 |
| (01) 00849111003384 | 1121 |
| (01) 00849111003384 | 1122 |
| (01) 00849111003384 | 1123 |
| (01) 00849111003384 | 1107 |
| (01) 00849111003384 | 1112 |
| (01) 00849111003384 | 1113 |
| (01) 00849111003384 | 1114 |
| (01) 00849111003384 | 1115 |
| (01) 00849111003384 | 1137 |
| (01) 00849111003384 | 1140 |
| (01) 00849111003384 | 1196 |
FDA Approves Novel Device for Pancreatic Cancer Treatment
FDA Approves Novel Device for Pancreatic Cancer Treatment The U.S. Food and Drug Administration has approved Optune Pax, a first-of-its-kind medical device designed to treat adult patients with locally advanced pancreatic cancer. Developed by Novocure, the portable...
When Apparel Becomes a Medical Device
Lessons from FDA’s Breast Binder Warning Letters In December 2025, the FDA issued warning letters to several companies selling breast binders and chest compression garments online. The agency concluded that marketing claims on company websites, like statements about...